Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

DACARBAZINE

DACARBAZINE

Standard Dose
100MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview DACARBAZINE is listed in Drugs@FDA under application 075371 (ANDA).

Marketing status: Prescription Active ingredient DACARBAZINE Form and strength INJECTABLE;INJECTION - 100MG/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 1999-08-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview DACARBAZINE is listed in Drugs@FDA under application 075371 (ANDA). Marketing status: Prescription Active ingredient DACARBAZINE Form and strength INJECTABLE;INJECTION - 100MG/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 1999-08-27 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.